{"title":"Oncology","description":"\u003cp\u003eExplore product information in oncology. Compare the exact presentation, current label and listed availability before choosing your next step.\u003c\/p\u003e","products":[{"product_id":"palladia-toceranib-phosphate-tablets-s16","title":"Palladia Toceranib Phosphate Tablets","description":"\u003cp\u003ePalladia contains toceranib phosphate in prescription tablets. Its US reference concerns recurrent grade II or III cutaneous mast-cell tumours in dogs. The required strength is selected within a veterinarian-led oncology plan.\u003c\/p\u003e\u003ch3\u003eProduct features at a glance\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eToceranib phosphate prescription tablets.\u003c\/li\u003e\n\u003cli\u003eSelect 10, 15 or 50 mg as prescribed; separate 30-tablet packs.\u003c\/li\u003e\n\u003cli\u003eWhole-tablet handling and veterinary oncology follow-up.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eA targeted kinase-inhibitor ingredient\u003c\/h3\u003e\u003cp\u003eToceranib acts at several receptor tyrosine kinases involved in cell signalling. The reference identifies KIT, VEGFR and PDGFR among the targets. A targeted mechanism does not mean the product is a general treatment for every tumour or every animal.\u003c\/p\u003e\u003ch3\u003eChoose one prescribed 30-tablet presentation\u003c\/h3\u003e\u003cp\u003eThe selectable options are 10 mg × 30, 15 mg × 30 and 50 mg × 30 tablets. Each option is a separate strength-specific pack. The photograph of the range is not a mixed-strength bundle.\u003c\/p\u003e\u003ch3\u003eWhole tablets and handling precautions\u003c\/h3\u003e\u003cp\u003eThe label says not to split tablets. Use gloves when handling and follow the precautions for damaged tablets and animal waste. These precautions belong to the product’s oncology use and should stay with the prescription instructions.\u003c\/p\u003e\u003ch3\u003eKeep follow-up and product identity together\u003c\/h3\u003e\u003cp\u003eThe clinical team determines the strength and monitoring plan. Include the selected pack and prescription details with a refill enquiry. A tablet count identifies the supply quantity, while treatment duration is a separate clinical decision.\u003c\/p\u003e","brand":"Vetra Recare","offers":[{"title":"10 mg × 30 tablets","offer_id":53490500206773,"sku":"S16-10MG","price":700.0,"currency_code":"USD","in_stock":false},{"title":"15 mg × 30 tablets","offer_id":53490505810101,"sku":"S16-15MG","price":800.0,"currency_code":"USD","in_stock":false},{"title":"50 mg × 30 tablets","offer_id":53490505842869,"sku":"S16-50MG","price":1700.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1035\/3029\/9573\/files\/S16.webp?v=1791369479"},{"product_id":"palladia-toceranib-phosphate-tablets-h17","title":"Palladia Toceranib Phosphate Tablets","description":"\u003cp\u003ePalladia is the named toceranib-phosphate tablet brand. An oncology enquiry should identify the prescribed strength and branded 30-tablet pack, together with the veterinary treatment instructions.\u003c\/p\u003e\u003ch3\u003eWhat the reference medicine targets\u003c\/h3\u003e\u003cp\u003eThe ingredient is a multi-kinase inhibitor acting on receptor tyrosine kinases. The US dog reference concerns a specified cutaneous mast-cell tumour setting; it does not establish a universal cancer indication or a cat-specific label.\u003c\/p\u003e\u003ch3\u003eBrand, strength and count matter together\u003c\/h3\u003e\u003cp\u003eThe listed presentations are 10 mg × 30, 15 mg × 30 and 50 mg × 30 tablets. A different bottle labelled only toceranib should be compared by its full product identity. The ingredient name alone does not establish a Palladia brand match.\u003c\/p\u003e\u003ch3\u003eHandling whole tablets\u003c\/h3\u003e\u003cp\u003eKeep tablets whole as directed by the label. Follow the handling precautions, including gloves and the instructions for damaged tablets and waste. A stronger tablet should not be chosen with the intention of recreating another strength by splitting.\u003c\/p\u003e\u003ch3\u003eA specific enquiry supports the clinical plan\u003c\/h3\u003e\u003cp\u003eRequest the exact branded presentation named by the veterinary team. Keep monitoring arrangements and other treatment recorded for that discussion. Product packaging information helps identify supply, while the clinical assessment determines how the medicine is used.\u003c\/p\u003e","brand":"Vetra Recare","offers":[{"title":"Default Title","offer_id":53490503581877,"sku":"H17","price":0.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1035\/3029\/9573\/files\/H17.webp?v=1791720647"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1035\/3029\/9573\/collections\/S16_5050aa91-83b4-488d-896c-5dd14176203f.webp?v=1791369707","url":"https:\/\/www.vetrarecare.com\/collections\/oncology.oembed","provider":"Vetra Recare","version":"1.0","type":"link"}